Imaging the Male Reproductive Tract: Current Trends and Future Directions

Radiologic Clinics of North America

Volumn 46, Issue 1, 2008, Pages 133-147

  Fütterer, Jurgen J ^a   Heijmink, Stijn W T P J ^a   Spermon, J Roan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER STAGING; CONTRAST ENHANCEMENT; CRYPTORCHISM; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DRUG UPTAKE; ELASTOGRAPHY; EPIDIDYMIS; GERM CELL TUMOR; GRAY SCALE ECHOGRAPHY; HUMAN; HYDROCELE; IMAGING SYSTEM; INGUINAL HERNIA; MALE GENITAL SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHITIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCROTAL PAIN; SCROTUM; SPERMATOCELE; TESTIS TORSION; TRANSRECTAL ULTRASONOGRAPHY; VARICOCELE;

DIAGNOSTIC IMAGING; GENITAL DISEASES, MALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PROSTATIC DISEASES; SCROTUM;

EID: 40049111807     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2008.01.005     Document Type: Review

References (97)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
2. Krieger J.N., Riley D.E., Cheah P.Y., et al. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol 21 (2003) 70-74
3. Kravchick S., Cytron S., Agulansky L., et al. Acute prostatitis in middle-aged men: a prospective study. BJU Int 93 (2004) 93-96
4. Griffiths G.J., Crooks A.J., Roberts E.E., et al. Ultrasonic appearances associated with prostatic inflammation: a preliminary study. Clin Radiol 35 (1984) 343-345
5. Horcajada J.P., Vilana R., Moreno-Martinez A., et al. Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35 (2003) 114-120
6. Shukla-Dave A., Hricak H., Eberhardt S.C., et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology 231 (2004) 717-724
7. Schiebler M.L., Tomaszeweski J.E., Bezzi M., et al. Prostatic carcinoma and bening prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 172 (1989) 111-137
8. Lee F., Gray J.M., McLeary R.D., et al. Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinoma. Radiology 158 (1986) 91-95
9. Ellis W.J., and Brawer M.K. The significance of isoechoic prostatic carcinoma. J Urol 152 (1994) 2304-2307
10. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-74
11. Vashi A.R., Wojno K.J., Gillespie B., et al. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 159 (1998) 920-924
12. Djavan B., Remzi M., and Marberger M. When to biopsy and when to stop biopsying. Urol Clin North Am 30 (2003) 253-262 viii
13. Presti Jr. J.C. Prostate biopsy: how many cores are enough?. Urol Oncol 21 (2003) 135-140
14. Eichler K., Hempel S., Wilby J., et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175 (2006) 1605-1612
15. Jang T.L., Han M., Roehl K.A., et al. More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects. Urology 67 (2006) 343-348
16. Ekici S., Ozen H., Agildere M., et al. A comparison of transrectal ultrasonography and endorectal magnetic resonance imaging in the local staging of prostatic carcinoma. BJU Int 83 (1999) 796-800
17. May F., Treumann T., Dettmar P., et al. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87 (2001) 66-69
18. Garg S., Fortling B., Chadwick D., et al. Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol 162 (1999) 1318-1321
19. Strasser H, Frauscher F, Klauser A, et al. Three-dimensional transrectal ultrasound instaging of localised prostate cancer. AUA Poster presentation 2003.
20. Mitterberger M., Pinggera G.M., Pallwein L., et al. The value of three-dimensional transrectal ultrasonography in staging prostate cancer. BJU Int 100 (2007) 47-50
21. Freedland S.J., Sutter M.E., Dorey F., et al. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 61 (2003) 365-369
22. Boccon-Gibod L., Djavan W.B., Hammerer P., et al. Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract 58 (2004) 382-390
23. Parra R.O., Wolf R.M., and Huben R.P. The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation. J Urol 144 (1990) 707-709
24. Foster L.S., Jajodia P., Fournier Jr. G., et al. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 149 (1993) 1024-1028
25. Salomon C.G., Flisak M.E., Olson M.C., et al. Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence. Radiology 189 (1993) 713-719
26. Leventis A.K., Shariat S.F., and Slawin K.M. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 219 (2001) 432-439
27. Wasserman N.F., Kapoor D.A., Hildebrandt W.C., et al. Transrectal US in evaluation of patients after radical prostatectomy. Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer. Radiology 185 (1992) 367-372
28. Connolly J.A., Shinohara K., Presti Jr. J.C., et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 47 (1996) 225-231
29. Saleem M.D., Sanders H., Abu E.N., et al. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. Urology 51 (1998) 283-286
30. Scattoni V., Roscigno M., Raber M., et al. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 44 (2003) 407-414
31. Naya Y., Okihara K., Evans R.B., et al. Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy. Urology 66 (2005) 350-355
32. Tang J., Li S., Li J., et al. Correlation between prostate cancer grade and vascularity on color doppler imaging: preliminary findings. J Clin Ultrasound 31 (2003) 61-68
33. Heijmink S.W., and Barentsz J.O. Contrast-enhanced versus systematic transrectal ultrasound-guided prostate cancer detection: an overview of techniques and a systematic review. Eur J Radiol 63 (2007) 310-316
34. Okihara K., Kojima M., Nakanouchi T., et al. Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 85 (2000) 1053-1057
35. Ismail M., Petersen R.O., Alexander A.A., et al. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 50 (1997) 906-912
36. Sauvain J.L., Palascak P., Bourscheid D., et al. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 44 (2003) 21-30
37. Sudakoff G.S., Smith R., Vogelzang N.J., et al. Color Doppler imaging and transrectal sonography of the prostatic fossa after radical prostatectomy: early experience. AJR Am J Roentgenol 167 (1996) 883-888
38. Tamsel S., Killi R., Apaydin E., et al. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy. Clin Radiol 61 (2006) 325-330
39. Halpern E.J., Rosenberg M., and Gomella L.G. Prostate cancer: contrast-enhanced us for detection. Radiology 219 (2001) 219-225
40. Mitterberger M., Pinggera G.M., Horninger W., et al. Comparison of contrast enhanced color doppler targeted biopsy to conventional systematic biopsy: impact on gleason score. J Urol 178 (2007) 464-468 [discussion: 468]
41. Pelzer A., Bektic J., Berger A.P., et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173 (2005) 1926-1929
42. Heijmink S.W., van Moerkerk H., Kiemeney L.A., et al. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol 16 (2006) 927-938
43. Jakobsen J.A., Oyen R., Thomsen H.S., et al. Safety of ultrasound contrast agents. Eur Radiol 15 (2005) 941-945
44. Ophir J., Cespedes I., Ponnekanti H., et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13 (1991) 111-134
45. Phipps S., Yang T.H., Habib F.K., et al. Measurement of tissue mechanical characteristics to distinguish between benign and malignant prostatic disease. Urology 66 (2005) 447-450
46. Konig K., Scheipers U., Pesavento A., et al. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 174 (2005) 115-117
47. Pallwein L., Mitterberger M., Pinggera G., et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur J Radiol (2007) [epub ahead of print]
48. Pallwein L., Mitterberger M., Struve P., et al. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol 17 (2007) 2278-2285
49. Albertsen P.C., Hanley J.A., Harlan L.C., et al. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol 163 (2000) 1138-1143
50. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 19 (2003) 2491-2499
51. Beyersdorff D., Taupitz M., Winkelmann B., et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224 (2002) 701-706
52. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
53. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
54. Testa C., Schiavina R., Lodi R., et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-Choline PET/CT. Radiology 244 3 (2007) 797-806
55. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189 2 (2007) 323-328
56. Sonnad S.S., Langlotz C.P., and Schwartz J.S. Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad Radiol 8 (2001) 149-157
57. Engelbrecht M.R., Jager G.J., Laheij R.J., et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12 (2002) 2294-2302
58. Futterer J.J., Engelbrecht M.R., Jager G.J., et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17 (2007) 1055-1065
59. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer: local staging at 3-T endorectal MR imaging-early experience. Radiology 238 (2006) 184-191
60. Scheenen T.W., Heijmink S.W., Roell S.A., et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology (2007) [epub ahead of print]
61. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
62. Anderson A.W., Xie J., Pizzonia J., et al. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 18 (2000) 689-695
63. In: Wein A.J., Kavoussi L.R., Novick A.C., et al. (Eds). Campbell-Walsh urology. 8th edition (2007), Saunders, Philadelphia
64. Nguyen H.T., Coakley F., and Hricak H. Cryptorchidism: strategies in detection. Eur Radiol 9 (1999) 336-343
65. Weiss R., Carter A.R., and Rosenfield A.T. High-resolution real-time ultrasound in the localization of the undescended testis. J Urol 135 (1986) 936-938
66. Muglia V., Tucci Jr. S., Elias Jr. J., et al. Magnetic resonance imaging of scrotal diseases: when it makes the difference. Urology 59 (2002) 419-423
67. Horstman W.G. Scrotal imaging. Urol Clin North Am 24 (1997) 653-671
68. Berman J.M., Beidle T.R., Kunberger L.E., et al. Sonographic evaluation of acute intrascrotal pathology. AJR Am J Roentgenol 166 (1996) 857-861
69. Barth R.A., and Shortliffe L.D. Normal pediatric testis: comparison of power Doppler and color Doppler US in the detection of blood flow. Radiology 204 (1997) 389-393
70. Luker G.D., and Siegel M.J. Scrotal US in pediatric patients: comparison of power and standard color Doppler US. Radiology 198 (1996) 381-385
71. Terai A., Yoshimura K., Ichioka K., et al. Dynamic contrast-enhanced subtraction magnetic resonance imaging in diagnostics of testicular torsion. Urology 67 (2006) 1278-1282
72. Cohen H.L., Shapiro M.A., Haller J.O., et al. Torsion of the testicular appendage sonographic diagnosis. J Ultrasound Med 11 (1992) 81-83
73. Strauss S., Faingold R., and Manor H. Torsion of the testicular appendagesonographic appearance. J Ultrasound Med 16 (1997) 189-192
74. Aso C., Enriquez G., Fite M., et al. Gray-scale and color Doppler sonography of scrotal disorders in children: an update. Radiographics 25 (2005) 1197-1214
75. Burks D.D., Markey B.J., Burkhard T.K., et al. Suspected testicular torsion and ischemia: evaluation with color Doppler sonography. Radiology 175 (1990) 815-821
76. Middleton W.D., Siegel B.A., Melson G.L., et al. Acute scrotal disorders: prospective comparison of color Doppler US and testicular scintigraphy. Radiology 177 (1990) 177-181
77. Andipa E., Liberopoulos K., and Asvestis C. Magnetic resonance imaging and ultrasound evaluation of penile and testicular masses. World J Urol 22 (2004) 382-391
78. Sica G.T., and Teeger S. MR imaging of scrotal, testicular, and penile diseases. Magn Reson Imaging Clin N Am 4 (1996) 545-563
79. Jamadar D.A., Jacobson J.A., Morag Y., et al. Sonography of inguinal region hernias. AJR Am J Roentgenol 187 (2006) 185-190
80. Lilly M.C., and Arregui M.E. Ultrasound of the inguinal floor for evaluation of hernias. Surg Endosc 16 (2002) 659-662
81. Kraft B.M., Kolb H., Kuckuk B., et al. Diagnosis and classification of inguinal hernias. Surg Endosc 17 (2003) 2021-2024
82. van den Berg J.C., de Valois J.C., Go P.M., et al. Detection of groin hernia with physical examination, ultrasound, and MRI compared with laparoscopic findings. Invest Radiol 34 (1999) 739-743
83. Tessler F.N., Tublin M.E., and Rifkin M.D. Ultrasound assessment of testicular and paratesticular masses. J Clin Ultrasound 24 (1996) 423-436
84. Garner M.J., Turner M.C., Ghadirian P., et al. Epidemiology of testicular cancer: an overview. Int J Cancer 116 (2005) 331-339
85. Hricak H. Imaging of the scrotum. Textbook and atlas (1995), Raven press, New York p. 49-93
86. Schwerk W.B., Schwerk W.N., and Rodeck G. Testicular tumors: prospective analysis of real-time US patterns and abdominal staging. Radiology 164 (1987) 369-374
87. Backus M.L., Mack L.A., Middleton W.D., et al. Testicular microlithiasis: imaging appearances and pathologic correlation. Radiology 192 (1994) 781-785
88. Peckham M.J., Barrett A., McEwlain T.J., et al. Non-seminoma germ cell tumours (malignant teratomas) of the testis. Br J Urol 53 (1981) 162-172
89. Hilton S., Herr H.W., Teitcher J.B., et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol 169 (1997) 521-525
90. Albers P., Bender H., Yilmaz H., et al. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 53 (1999) 808-811
91. Muller-Mattheis V., Reinhardt M., Gerharz C.D., et al. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors]. Urologe A 37 (1998) 609-620 [in German]
92. Spermon J.R., De Geus-Oei L.F., Kieinmeney L.A., et al. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89 (2002) 549-556
93. Ellis J.H., Bies J.R., Kopecky K.K., et al. Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr 8 (1984) 709-719
94. Hogeboom W.R., Hoekstra H.J., Mooyaart E.L., et al. The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors. Eur J Radiol 13 (1991) 31-36
95. Harisinghani M.G., Saksena M., Ross R.W., et al. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology 66 (2005) 1066-1071
96. Flechon A., Bompas E., Biron P., et al. Management of post-chemotherapy residual masses in advanced seminoma. J Urol 168 (2002) 1975-1979
97. De Santis M., Becherer A., Bokemeyer C., et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22 (2004) 1034-1039